| UniProt ID | TCTP_HUMAN | |
|---|---|---|
| UniProt AC | P13693 | |
| Protein Name | Translationally-controlled tumor protein | |
| Gene Name | TPT1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 172 | |
| Subcellular Localization | Cytoplasm . | |
| Protein Description | Involved in calcium binding and microtubule stabilization.. | |
| Protein Sequence | MIIYRDLISHDEMFSDIYKIREIADGLCLEVEGKMVSRTEGNIDDSLIGGNASAEGPEGEGTESTVITGVDIVMNHHLQETSFTKEAYKKYIKDYMKSIKGKLEEQRPERVKPFMTGAAEQIKHILANFKNYQFFIGENMNPDGMVALLDYREDGVTPYMIFFKDGLEMEKC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 4 | Phosphorylation | ----MIIYRDLISHD ----CCCCCCCCCCH | 6.27 | 21406692 | |
| 9 | Phosphorylation | IIYRDLISHDEMFSD CCCCCCCCCHHHHHH | 31.98 | 21406692 | |
| 13 | Sulfoxidation | DLISHDEMFSDIYKI CCCCCHHHHHHHHHH | 4.92 | 21406390 | |
| 15 | Phosphorylation | ISHDEMFSDIYKIRE CCCHHHHHHHHHHHH | 23.07 | 21406692 | |
| 18 | Phosphorylation | DEMFSDIYKIREIAD HHHHHHHHHHHHHHC | 12.83 | 21406692 | |
| 19 | Acetylation | EMFSDIYKIREIADG HHHHHHHHHHHHHCC | 35.30 | 23236377 | |
| 19 | 2-Hydroxyisobutyrylation | EMFSDIYKIREIADG HHHHHHHHHHHHHCC | 35.30 | - | |
| 19 | Ubiquitination | EMFSDIYKIREIADG HHHHHHHHHHHHHCC | 35.30 | 21890473 | |
| 28 | Glutathionylation | REIADGLCLEVEGKM HHHHCCCEEEEECEE | 3.58 | 22555962 | |
| 37 | Phosphorylation | EVEGKMVSRTEGNID EEECEEEECCCCCCC | 29.95 | 26074081 | |
| 39 | Phosphorylation | EGKMVSRTEGNIDDS ECEEEECCCCCCCCC | 40.51 | 30175587 | |
| 46 | Phosphorylation | TEGNIDDSLIGGNAS CCCCCCCCCCCCCCC | 20.38 | 30175587 | |
| 53 | Phosphorylation | SLIGGNASAEGPEGE CCCCCCCCCCCCCCC | 30.74 | 28674151 | |
| 62 | Phosphorylation | EGPEGEGTESTVITG CCCCCCCCCCEEEEE | 23.59 | 24732914 | |
| 64 | Phosphorylation | PEGEGTESTVITGVD CCCCCCCCEEEEECC | 28.01 | 24732914 | |
| 65 | O-linked_Glycosylation | EGEGTESTVITGVDI CCCCCCCEEEEECCC | 15.08 | OGP | |
| 65 | Phosphorylation | EGEGTESTVITGVDI CCCCCCCEEEEECCC | 15.08 | 24732914 | |
| 68 | Phosphorylation | GTESTVITGVDIVMN CCCCEEEEECCCHHC | 27.15 | 24732914 | |
| 78 | Ubiquitination | DIVMNHHLQETSFTK CCHHCCCCCCCCCCH | 3.70 | 21890473 | |
| 81 | Phosphorylation | MNHHLQETSFTKEAY HCCCCCCCCCCHHHH | 19.04 | 27251275 | |
| 82 | Phosphorylation | NHHLQETSFTKEAYK CCCCCCCCCCHHHHH | 30.11 | 24732914 | |
| 84 | Phosphorylation | HLQETSFTKEAYKKY CCCCCCCCHHHHHHH | 27.95 | 27251275 | |
| 88 | Phosphorylation | TSFTKEAYKKYIKDY CCCCHHHHHHHHHHH | 14.76 | 22817900 | |
| 90 | Malonylation | FTKEAYKKYIKDYMK CCHHHHHHHHHHHHH | 39.26 | 26320211 | |
| 91 | Phosphorylation | TKEAYKKYIKDYMKS CHHHHHHHHHHHHHH | 14.73 | 28152594 | |
| 93 | Ubiquitination | EAYKKYIKDYMKSIK HHHHHHHHHHHHHHC | 39.45 | 19608861 | |
| 93 | Acetylation | EAYKKYIKDYMKSIK HHHHHHHHHHHHHHC | 39.45 | 23749302 | |
| 93 | Malonylation | EAYKKYIKDYMKSIK HHHHHHHHHHHHHHC | 39.45 | 26320211 | |
| 95 | Phosphorylation | YKKYIKDYMKSIKGK HHHHHHHHHHHHCCH | 11.05 | 28152594 | |
| 97 | 2-Hydroxyisobutyrylation | KYIKDYMKSIKGKLE HHHHHHHHHHCCHHH | 42.68 | - | |
| 97 | Malonylation | KYIKDYMKSIKGKLE HHHHHHHHHHCCHHH | 42.68 | 26320211 | |
| 97 | Ubiquitination | KYIKDYMKSIKGKLE HHHHHHHHHHCCHHH | 42.68 | 19608861 | |
| 97 | Acetylation | KYIKDYMKSIKGKLE HHHHHHHHHHCCHHH | 42.68 | 23749302 | |
| 102 | Sumoylation | YMKSIKGKLEEQRPE HHHHHCCHHHHHCCH | 47.96 | - | |
| 102 | Acetylation | YMKSIKGKLEEQRPE HHHHHCCHHHHHCCH | 47.96 | 23749302 | |
| 102 | Ubiquitination | YMKSIKGKLEEQRPE HHHHHCCHHHHHCCH | 47.96 | - | |
| 102 | Sumoylation | YMKSIKGKLEEQRPE HHHHHCCHHHHHCCH | 47.96 | - | |
| 112 | Sumoylation | EQRPERVKPFMTGAA HHCCHHCCCCHHCHH | 38.47 | - | |
| 112 | 2-Hydroxyisobutyrylation | EQRPERVKPFMTGAA HHCCHHCCCCHHCHH | 38.47 | - | |
| 112 | Sumoylation | EQRPERVKPFMTGAA HHCCHHCCCCHHCHH | 38.47 | 19608861 | |
| 112 | Malonylation | EQRPERVKPFMTGAA HHCCHHCCCCHHCHH | 38.47 | 26320211 | |
| 112 | Ubiquitination | EQRPERVKPFMTGAA HHCCHHCCCCHHCHH | 38.47 | 19608861 | |
| 112 | Acetylation | EQRPERVKPFMTGAA HHCCHHCCCCHHCHH | 38.47 | 23954790 | |
| 115 | Sulfoxidation | PERVKPFMTGAAEQI CHHCCCCHHCHHHHH | 4.60 | 28465586 | |
| 116 | Phosphorylation | ERVKPFMTGAAEQIK HHCCCCHHCHHHHHH | 24.85 | 20068231 | |
| 123 | Acetylation | TGAAEQIKHILANFK HCHHHHHHHHHHHCC | 25.04 | 21466224 | |
| 123 | Ubiquitination | TGAAEQIKHILANFK HCHHHHHHHHHHHCC | 25.04 | - | |
| 130 | Sumoylation | KHILANFKNYQFFIG HHHHHHCCCCEEEEE | 55.33 | - | |
| 130 | Methylation | KHILANFKNYQFFIG HHHHHHCCCCEEEEE | 55.33 | - | |
| 130 | Ubiquitination | KHILANFKNYQFFIG HHHHHHCCCCEEEEE | 55.33 | 21890473 | |
| 159 | Phosphorylation | REDGVTPYMIFFKDG CCCCCCEEEEEECCC | 8.09 | 20393185 | |
| 164 | Sumoylation | TPYMIFFKDGLEMEK CEEEEEECCCCCEEC | 39.89 | - | |
| 164 | Ubiquitination | TPYMIFFKDGLEMEK CEEEEEECCCCCEEC | 39.89 | 21890473 | |
| 169 | Sulfoxidation | FFKDGLEMEKC---- EECCCCCEECC---- | 7.78 | 30846556 | |
| 171 | Ubiquitination | KDGLEMEKC------ CCCCCEECC------ | 43.89 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TCTP_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TCTP_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| DREB_HUMAN | DBN1 | physical | 21900206 | |
| RLA1_HUMAN | RPLP1 | physical | 21900206 | |
| P53_HUMAN | TP53 | physical | 22157679 | |
| MDM2_HUMAN | MDM2 | physical | 22912717 | |
| A4_HUMAN | APP | physical | 21832049 | |
| B2CL1_HUMAN | BCL2L1 | physical | 15870695 | |
| MCL1_HUMAN | MCL1 | physical | 15870695 | |
| TBB2A_HUMAN | TUBB2A | physical | 15870695 | |
| VHL_HUMAN | VHL | physical | 23387829 | |
| PCH2_HUMAN | TRIP13 | physical | 25416956 | |
| CALR_HUMAN | CALR | physical | 26344197 | |
| PEPL1_HUMAN | NPEPL1 | physical | 26344197 | |
| SAMD9_HUMAN | SAMD9 | physical | 26344197 | |
| LACC1_HUMAN | LACC1 | physical | 28514442 | |
| CYTF_HUMAN | CST7 | physical | 28514442 | |
| EF1A2_HUMAN | EEF1A2 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-93, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46 AND SER-53, AND MASSSPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46, AND MASSSPECTROMETRY. | |
| "Plk phosphorylation regulates the microtubule-stabilizing proteinTCTP."; Yarm F.R.; Mol. Cell. Biol. 22:6209-6221(2002). Cited for: PHOSPHORYLATION AT SER-46 AND SER-64. | |